Cardiovascular
In this section you will find Therapeutics Diseases & Conditions Cardiovascular market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Cardiac Marker Diagnostic Testing Markets
€2,700.00Published by TriMark Publications LLC on Nov 1st, 2011Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac... Learn More -
Cardiac Rhythm Management Devices World Markets
€849.00Published by TriMark Publications LLC on Oct 1st, 2011This TriMark Publications report reviews the worldwide cardiac rhythm management market size for the U.S., European and Asian markets. Individual country markets such as Japan, the Philippines, Australia, and the... Learn More -
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
€1,968.00Published by Visiongain on May 6th, 2011what are the revenue prospects there?What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to... Learn More -
Nuclear Cardiology Markets
€1,699.00Published by TriMark Publications LLC on May 2nd, 2011Nuclear imaging for cardiac diseases helps in accurately diagnosing the disease and blood flow blockages.Gamma cameras and positron emission tomography (PET) scanners are the key imaging devices used for... Learn More -
Statins: World Market Outlook 2011-2021
€1,968.00Published by Visiongain on Mar 3rd, 2011what will happen now in the statin drugs market?What does the future hold for the statins industry and market? Our new report shows how the patent expiry of Lipitor... Learn More -
Antithrombotic/Anticoagulant Drugs: World Market Prospects 2010-2025
€1,739.00Published by Visiongain on Sep 17th, 2010Where you can find opportunities in this market.Our new report will show you how the market for antithrombotic and anticoagulant drugs will develop. You can indentify where the greatest... Learn More -
Hypertension: Competing Treatments and Market Entry Considerations
€7,190.00Published by BioPharm Reports on Jun 1st, 2010This report presents the findings of a global survey on current treatments and prescribing practices for Hypertension. These findings were made following the participation of more than 280 clinics worldwide... Learn More -
Global Diagnostic ECG Market (2010 - 2015)
€3,720.00Published by on Apr 14th, 2010The global diagnostic ECG market is categorized into three submarkets: the rest systems the stress systems and holter systems. These systems are used to measure the electrical activity of the... Learn More -
Statins: The World Market 2010-2025
€1,739.00Published by Visiongain on Feb 8th, 2010The world statins market is facing rapid change. From 2010 onwards, there will be major patent expires – most notably for Lipitor - maturity of products, and rising competition from generic alternatives. Learn More -
Global Cardiovascular Drugs Market 2009-2024
€1,739.00Published by Visiongain on Jun 30th, 2009The years 2011 to 2015 will mark a period of high volatility in the cardiovascular market as key products - including blockbusters Plavix and Lovenox - face patent expiry. What types of therapeutic agent will enter the market from 2009 onwards, and what are their sales prospects? Learn More -
Blood Disorders Market Analysis & Forecasts Report to 2013
€1,739.00Published by Visiongain on Apr 14th, 2008In 2006 visiongain valued this market at $37406m, But do you know how the blood diseases treatments market will fare 5, 10 and 15 years from now? Learn More -
The World Hypertension Market 2005-2010
€1,739.00Published by Visiongain on Nov 3rd, 2005The world hypertension market generated over $25 billion in 2004, with steady growth from the previous year. In this report, visiongain forecasts that revenues in the world hypertension market will grow to nearly $30 billion per year by 2010… Learn More

